< Back to all Breaking News
SYGGF
10/20/2021 07:10am
Synairgen's SNG001 advancing to Phase 3 of ACTIV-2 COVID-19 trial 
Don't miss out!
We read the Wall Street research, SEC filings and press releases so you don't have to.
Sign up for our 14-day free trial to read this story.
